Getting The Deal Through logo
Getting The Deal Through


Ropes & Gray hires from Johnson & Johnson in Shanghai

Pharma - News – 13 November 2018

Ropes & Gray has announced that Johnson & Johnson counsel Eric Wu is to re-join its Shanghai office as a life sciences partner.


China mulls new clinical trials rules

Pharma - News – 13 November 2018

China has issued clinical study guidelines for drugs treating bipolar disorder and schizophrenia.


McCarter & English adds two patent partners in Boston

Pharma - News – 13 November 2018

US McCarter & English has recruited IP lawyers John Gutkoski and Jonathan Lovely as partners in its Boston office.


EMA issues new guidance on paediatric pharmacovigilance practice

Pharma - News – 13 November 2018

The European Medicines Agency has released new guidelines for good pharmacovigilance practice (GVP) in paediatric populations.


The PLN Round-up (13 November)

Pharma - The Round-up – 13 November 2018

News in brief from around the world… MPs have written to US pharma company Vertex to demand information on its negotiations with the NHS, China has announced new vaccine regulations and a US appeals court has affirmed Fresenius’s Diprivan patent loss.


Corporate Counsel Q&A – Iain Ward, GW Pharma

Pharma - Features – 06 November 2018

On 1 November, cannabis-based epilepsy treatment Epidiolex went on sale throughout the US, having become the first drug incorporating non-synthetic cannabidiol to win FDA approval over the summer. In our latest in-house Q&A, PLN caught up with Epidiolex manufacturer GW Pharmaceutical’s general counsel Iain Ward.






Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn